Your browser doesn't support javascript.
loading
First reported case of Doyne honeycomb retinal dystrophy (Malattia Leventinese/autosomal dominant drusen) in Scandinavia.
Sheyanth, Inger Norlyk; Lolas, Ihab Bishara; Okkels, Henrik; Kiruparajan, Ligor Pradeep; Abildgaard, Søren Kromann; Petersen, Michael Bjørn.
Afiliação
  • Sheyanth IN; Research and Knowledge Center in Sensory Genetics, Aalborg University Hospital, Aalborg, Denmark.
  • Lolas IB; Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark.
  • Okkels H; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Kiruparajan LP; Research and Knowledge Center in Sensory Genetics, Aalborg University Hospital, Aalborg, Denmark.
  • Abildgaard SK; Department of Molecular Diagnostics, Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
  • Petersen MB; Research and Knowledge Center in Sensory Genetics, Aalborg University Hospital, Aalborg, Denmark.
Mol Genet Genomic Med ; 9(4): e1652, 2021 04.
Article em En | MEDLINE | ID: mdl-33689237
ABSTRACT

BACKGROUND:

Doyne honeycomb retinal dystrophy (DHRD)/malattia leventinese (ML) is an autosomal dominant, progressive retinal disorder characterized by massive central retinal drusen often partly coalescent forming a characteristic honeycomb-like pattern. Debut of vision loss often occurs in early to mid-adulthood, and the degree varies. A single variant in EFEMP1 c.1033C>T (R345W) has been identified as the cause in all cases.

METHODS:

Following DNA isolation, exome sequencing was performed in seven genes associated with flecked retina. Direct sequencing was used for variant verification.

RESULTS:

We report the first Scandinavian case of molecular genetically verified DHRD/ML a 57-year-old woman debuting with vision loss and metamorphopsia. On both eyes, ophthalmological findings included massive hard drusen in the macular region and nasal to the optic disc as well as macular hyperpigmentation. Secondary choroidal neovascularizations were identified on both eyes, and anti-vascular endothelial growth factor was administered, without effect.

CONCLUSION:

Molecular genetic investigation revealed heterozygosity for the known pathogenic missense variant in EFEMP1 c.1033C>T (R345W) previously reported in relation to DHRD/ML. Family history revealed no other cases of similar visual impairment suggesting a de novo mutation. Furthermore, there was no correlation between the unique DHRD/ML haplotypes reported in the literature and our patient.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas da Matriz Extracelular Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Mol Genet Genomic Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas da Matriz Extracelular Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Mol Genet Genomic Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca
...